维普期刊资源整合服务平台（V6.5）

63篇 您的检索式：作者名="ASBERG A"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	Computer-assisted cyelosporine dosing performs better than traditional dosingin renal transplant recipients : results of a pilot study 显示文摘	Asberg A Falck P Undset LH	2010	Ther Drug Monit2010，32，2：	1
2	New-onset posttransplantation diabetes mellitus: insulin resistance or insulinopenia? Impact of immunosuppressive drugs, cytomegalovirus and hepatitis C virus infection 显示文摘	Hjelmesaeth J Asberg A MUller F	2005	Curt Diabetes Rev2005，1，1：	1
3	Calcineurin inhibitor avoidance with daclizumab, mycophenolate mofetil, and prednisolone in DR-matched de novo kidney transplant recipients 显示文摘	Asberg A Midtvedt K Line PD	2006	Transplantation2006，82，1：	1
4	Substantially elevated levels of atorvastatin and metabolites in cyclosporine-treated renal transplant recipients 显示文摘	HERMANN M ASBERG A CHRISTENSEN H	2004	Clin Pharmacol Ther2004，76，4：	1
5	Substantially elevated levels of atorvastatin and metabolites in cyclosporine-treated renal transplant recipients显示文摘	Asberg A Christensen H	2004	Clin Pharmacol Ther2004，76，4：	1
6	AtorvGOTatinimproves endothelial function in renal transplant recipients显示文摘	Asberg A hartmann A Fjeldsa E		0，，：	1
7	Validation of the modification of diet in renal disease formula for estimating GFR with special emphasis on calibration of the serum creatinine assay显示文摘	Hallan S Asberg A Lindberg M	2004	Am J Kidney Dis2004，44，1：	1
8	Diltiazem modulates cyclosporin A induced renal hemodynamic effects but not its effect on plasma endothelin-1显示文摘	Asberg A Christensen H Hartmann A	1998	Clin Transplant1998，12，5：	1
9	Psychoneuroendocrinology显示文摘	Jokinen J Chatzittofis A Hellstrom C Nordstrom P Uvnas-Moberg K Asberg M	2012	37(4):4822012，37，4：	1
10	Substantially elevated levels of atorvastatin and metabolites in eyclosporine treated renal transplant recipients显示文摘	Herrnann M Asberg A Christensen H	2004	Clin Pharmacol Ther2004，76，4：	1
11	Oral valganciclovir is noninferior to intravenous ganciclovir for the treatment of cytomegalovirus disease in solid organ transplant recipients显示文摘	Asberg A Humar A Rollag H	2007	Am J Transplant2007，7，9：	1
12	Long-term outcomes of CMV disease treatment with valganciclovir versus IV ganciclovir in solid organ transplant recipients显示文摘	Asberg A Humar A Jardine AG	2009	Am J Transplant2009，9，5：	1
13	Calcineurin inhibitor avoidance with daclizumab,mycophenolate mofetil,and prednisolone in DR-matched de novo kidney transplant recipients显示文摘	Asberg A Midtvedt K Line PD	2006	Transplantation2006，82，1：	1
14	AtorvGOTatin improves endothelial function in renal transplant recipients 显示文摘	ASBERG A HARTMANN A FJELDSA E	2001	Nephrol Dial Transplant2001，16，：	1
15	Risk factors for treatment related mortality in childhood acute lymphoblastic leukaemia显示文摘	Lund B Asberg A Heyman M	2011	Pediatr Blood Cancer2011，56，4：	1
16	Atorvastatin improves endothelial function in renal-transplant recipients显示文摘	Asberg A Hartmann A Fjeldsa E	2001	Nephrol Dial Transplant2001，16，：	1
17	Bilateral pharmacokinetic interaction between cyclosporine A and atorvastatin in renal transplant recipients 显示文摘	ASBERG A HARTMANN A FJELDSA E	2001	Am J Transplant2001，1，4：	1
18	Interactions between cyclosporin and lipid-lowering drugs: implications for organ transplant recipients rJ显示文摘	Asberg A	2003	Drugs2003，63，4：	1
19	Substantially elevated levels of atorvastatin and metabolites in cyclosporinetreated renal transplant recipients 显示文摘	HERMANN M ASBERG A CHRISTENSEN H	2004	Clin Pharmacol Ther2004，76，：	1
20	Evaluation of the pharmacokinetic interaction between fluvastatin XL and cyclosporine in renal transplant recipients显示文摘	HOLDAAS H HAGEN E ASBERG A	2006	Int J Clin Pharmacol Ther2006，44，4：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示